|
Neoplasia
Citations 171-180 of 4217 total displayed.
|
Past content
(since Jan 1997):
|
The kinase inhibitor dasatinib induces apoptosis in chronic lymphocytic leukemia cells in vitro with preference for a subgroup of patients with unmutated IgVH genes
- Aditya Veldurthy, Michaela Patz, Susanne Hagist, Christian P. Pallasch, Clemens-Martin Wendtner, Michael Hallek, and Günter Krause
Blood 2008; 112: 1443-1452.
[Abstract]
[Full text]
[PDF]
Failure to achieve a major cytogenetic response by 12 months defines inadequate response in patients receiving nilotinib or dasatinib as second or subsequent line therapy for chronic myeloid leukemia
- Constantine S. Tam, Hagop Kantarjian, Guillermo Garcia-Manero, Gautam Borthakur, Susan O'Brien, Farhad Ravandi, Jenny Shan, and Jorge Cortes
Blood 2008; 112: 516-518.
[Abstract]
[Full text]
[PDF]
Anti-CD38 antibody–mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells
- David C. Taussig, Farideh Miraki-Moud, Fernando Anjos-Afonso, Daniel J. Pearce, Kirsty Allen, Christopher Ridler, Debra Lillington, Heather Oakervee, Jamie Cavenagh, Samir G. Agrawal, T. Andrew Lister, John G. Gribben, and Dominique Bonnet
Blood 2008; 112: 568-575.
[Abstract]
[Full text]
[PDF]
Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines
- Michael A. Morse, Amy C. Hobeika, Takuya Osada, Delila Serra, Donna Niedzwiecki, H. Kim Lyerly, and Timothy M. Clay
Blood 2008; 112: 610-618.
[Abstract]
[Full text]
[PDF]
Reversible disruption of BCL6 repression complexes by CD40 signaling in normal and malignant B cells
- Jose M. Polo, Weimin Ci, Jonathan D. Licht, and Ari Melnick
Blood 2008; 112: 644-651.
[Abstract]
[Full text]
[PDF]
The antileukemia activity of a human anti-CD40 antagonist antibody, HCD122, on human chronic lymphocytic leukemia cells
- Mohammad Luqman, Sha Klabunde, Karen Lin, Georgios V. Georgakis, Anu Cherukuri, Jocelyn Holash, Cheryl Goldbeck, Xiaomei Xu, Edward E. Kadel, III, Sang Hoon Lee, Sharon Lea Aukerman, Bahija Jallal, Natasha Aziz, Wen-Kai Weng, William Wierda, Susan O'Brien, and Anas Younes
Blood 2008; 112: 711-720.
[Abstract]
[Full text]
[PDF]
Elevated protein tyrosine phosphatase activity provokes Eph/ephrin-facilitated adhesion of pre-B leukemia cells
- Sabine H. Wimmer-Kleikamp, Eva Nievergall, Kristina Gegenbauer, Samantha Adikari, Mariam Mansour, Trina Yeadon, Andrew W. Boyd, Neill R. Patani, and Martin Lackmann
Blood 2008; 112: 721-732.
[Abstract]
[Full text]
[PDF]
NOTCH1 extracellular juxtamembrane expansion mutations in T-ALL
- Maria Luisa Sulis, Odette Williams, Teresa Palomero, Valeria Tosello, Sasikala Pallikuppam, Pedro J. Real, Kelly Barnes, Linda Zuurbier, Jules P. Meijerink, and Adolfo A. Ferrando
Blood 2008; 112: 733-740.
[Abstract]
[Full text]
[PDF]
MDM2 SNP309 and TP53 Arg72Pro interact to alter therapy-related acute myeloid leukemia susceptibility
- Nathan A. Ellis, Dezheng Huo, Ozlem Yildiz, Lisa J. Worrillow, Mekhala Banerjee, Michelle M. Le Beau, Richard A. Larson, James M. Allan, and Kenan Onel
Blood 2008; 112: 741-749.
[Abstract]
[Full text]
[PDF]
Constitutive expression of IL-12Rβ2 on human multiple myeloma cells delineates a novel therapeutic target
- Irma Airoldi, Claudia Cocco, Nicola Giuliani, Marina Ferrarini, Simona Colla, Emanuela Ognio, Giuseppe Taverniti, Emma Di Carlo, Giovanna Cutrona, Vittorio Perfetti, Vittorio Rizzoli, Domenico Ribatti, and Vito Pistoia
Blood 2008; 112: 750-759.
[Abstract]
[Full text]
[PDF]
|
|
